Product Sku: 23598
Indications: probiotic protection in gastrointestinal disorders associated with antibiotics in children 3-18 years, from BioGaia Protectis.
Specifically, Lactobacillus reuteri DSM 17938, is a probiotic strain with proven safety and efficacy originally isolated from human breast milk. Additionally the security of L. reuteri Protectis, as shear treatment in gastrointestinal disorders related antibiotics have been studied in children and adults. Clinical studies have demonstrated the following: In 92% of hospitalized adult patients treated with antibiotics resulted in reducing the frequency of recurrence of diarrhea. 45% had a reduction of gastrointestinal symptoms in the group that was administered Protectis the following symptoms: diarrhea, constipation, abdominal distension, belching, epigastric pain, breath malodor.
Up to 25% of the general population receiving antibiotics and 40% of children receiving broad-spectrum antibiotics develop diarrhea associated with them. In many of these cases cause is the overgrowth of toxigenic bacterium clostridium difficile. The diarrhea may range from frequent loose or watery stools without further complications, to acute morbidity that requires surgery. Now there is an effective solution by picking the products of BioGaia series.
The saw is available in the form of drops of 5ml and tablets (30 chewable tablets) with strawberry flavor. Without sugar, lactose and gluten.
Along with diarrhea the high incidence of gastrointestinal disorders such as flatulence, stomach pain and other functional abdominal symptoms can lead to discontinuation of therapy with this risk of failure as well as the possible development of resistance of the organism to antibiotics.
